
Investments
2Partners & Customers
10About Elekta
Elekta is a human-care company focused on clinical solutions for treating cancer and brain disorders. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Want to inform investors similar to Elekta about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Elekta
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Elekta in 4 Expert Collections, including Health IT .
Health IT
2,589 items
Conference Exhibitors
5,302 items
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Medical Devices
3,501 items
https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.
Research containing Elekta
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Elekta in 1 CB Insights research brief, most recently on Dec 21, 2022.
Latest Elekta News
May 26, 2023
During radiation therapy, the placement and immobilisation of the patient are crucial. The firm that manufactures the radiation positioning equipment is aware of the needs of the radiotherapy professional and the patient’s comfort. During therapy sessions, the equipment offers the patient the perfect level of comfort and precision. With an estimated 11.5 million deaths from cancer in 2030, it is expected to become a more common cause of death globally. Surgery, chemotherapy, radiation treatment, hormone therapy, targeted therapy, precision medicine, immunotherapy, and stem cell transplantation are all options for treating cancer. To determine the potential of radiolabelled monoclonal antibodies, several clinical trials are now underway. The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. Request Sample @ It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years. Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Radiotherapy Positioning Devices Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast. The team of analysts at Future Market Insights are focussing on research and market study to produce different Radiotherapy Positioning Devices Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Radiotherapy Positioning Devices Market. Key Players The writer will create content on the general strategies of market players. And then will write the key players in the market are: CIVCO Radiotherapy, Elekta AB, Bionix Radiation Therapy, ORFIT INDUSTRIES NV, Qfix, VERTEC LTD Klarity Medical Products, Varian Medical Systems, Inc. and others Segmentation The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on: Ask a Question@ https://www.futuremarketinsights.com/ask-question/rep-gb-5898 Full in-depth analysis of the parent market The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics. For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-5898 Important changes in market dynamics The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future. Segmentation details of the market Former, on-going, and projected market analysis in terms of volume and value Assessment of niche industry developments Market share analysis Emerging segments and regional markets Queries Solved What is the size of the overall Radiotherapy Positioning Devices Market in the Healthcare Industry and its segments? What are the key segments and sub-segments in the market? What are the key drivers, restraints, opportunities, and challenges of the Radiotherapy Positioning Devices Market in the Healthcare Industry, and how they are expected to impact the market? What are the attractive investment opportunities within the Radiotherapy Positioning Devices Market in the Healthcare Industry? What is the Radiotherapy Positioning Devices Market in the Healthcare Industry size at the regional and country-level? What are the key market players focusing on? What are the strategies for growth adopted by the key players in Radiotherapy Positioning Devices Market in the Healthcare Industry? What are the recent trends in Radiotherapy Positioning Devices Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)? What are the challenges to the Radiotherapy Positioning Devices Market in the growth of the Healthcare Industry? What are the key market trends impacting the growth of the Radiotherapy Positioning Devices Market in the Healthcare Industry? Reasons to Buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. About Future Market Insights (FMI) Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact Us:
Elekta Investments
2 Investments
Elekta has made 2 investments. Their latest investment was in iRT Systems as part of their Corporate Minority on April 4, 2019.

Elekta Investments Activity

Elekta Acquisitions
13 Acquisitions
Elekta acquired 13 companies. Their latest acquisition was Özyürek on September 08, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/8/2021 | Acquired | 1 | ||||
5/19/2020 | Series A | $6.34M | Acquired | 1 | ||
2/21/2020 | Other | $2M | Acquired | 1 | ||
8/29/2019 | ||||||
7/27/2018 |
Date | 9/8/2021 | 5/19/2020 | 2/21/2020 | 8/29/2019 | 7/27/2018 |
---|---|---|---|---|---|
Investment Stage | Series A | Other | |||
Companies | |||||
Valuation | |||||
Total Funding | $6.34M | $2M | |||
Note | Acquired | Acquired | Acquired | ||
Sources | 1 | 1 | 1 |
Elekta Partners & Customers
10 Partners and customers
Elekta has 10 strategic partners and customers. Elekta recently partnered with Sinopharm on March 3, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
3/14/2023 | Partner | China | Elekta forms radiotherapy partnership with Sinopharm in China Elekta announced today that it entered into a joint venture with Sinopharm to increase the adoption of radiation therapy in China . | 2 | |
2/6/2023 | Partner | India | `` CHL 114 and Elekta 's collaboration is a step closer in the direction of leveraging advanced treatment options for cancer care . | 1 | |
10/14/2022 | Partner | India | Mumbai , Maharashtra , India -- Business Wire India Elekta and HealthCare Global Enterprises Limited announce the launch of a collaborative educational facility in Mumbai . | 3 | |
9/8/2022 | Partner | ||||
5/7/2022 | Partner |
Date | 3/14/2023 | 2/6/2023 | 10/14/2022 | 9/8/2022 | 5/7/2022 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | China | India | India | ||
News Snippet | Elekta forms radiotherapy partnership with Sinopharm in China Elekta announced today that it entered into a joint venture with Sinopharm to increase the adoption of radiation therapy in China . | `` CHL 114 and Elekta 's collaboration is a step closer in the direction of leveraging advanced treatment options for cancer care . | Mumbai , Maharashtra , India -- Business Wire India Elekta and HealthCare Global Enterprises Limited announce the launch of a collaborative educational facility in Mumbai . | ||
Sources | 2 | 1 | 3 |
Elekta Team
25 Team Members
Elekta has 25 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
Laurent Leksell | Founder | Current | |
Name | Laurent Leksell | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |
Compare Elekta to Competitors

MVision AI develops automatic segmentation and contouring software. The software integrates with hospital systems to provide contours of various critical structures. The company was founded in 2017 and is based in Helsinki, Finland.

TheraPanacea is a startup from the research laboratories of Inria and CentraleSupelec which provides software for radiation oncology. Using artificial intelligence technologies, the MedTech solutions allow for more effective treatment and reduction of side effects. The company was founded in 2017 and is based in Paris, France.

Mim Software is a medical device company known for developing the Mim 5.2 (brachy).

Manteia focuses on radiotherapy treatment system research and development. Manteia's product lines include automatic target volume delineation software, dose calculation and evaluation system, remote cloud system, and intelligent adaptive radiotherapy system.

Limbus AI is developing software for radiation therapy treatment planning.

Mirada Medical develops medical imaging software applications. It provides simple and accessible solutions to complex image analysis problems in the diagnosis and treatment of cancer and other diseases. Its products improve consistency and productivity while enabling clinicians to deliver more personalized care. It was founded in 2000 and is based in Oxford, United Kingdom.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.